Stock BNGO BIONANO GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Real-time Estimate Cboe BZX
Other stock markets
 02:59:30 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.868 USD +0.35% Intraday chart for Bionano Genomics, Inc. +9.18% -54.11%
Apr. 17 Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health MT
Apr. 17 Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bionano Genomics Names Gulsen Kama as Finance Chief, Suceeding Christopher Stewart
MT
Bionano Genomics, Inc. Announces Resignation of Richard Shippy as Chief Business Officer
CI
Bionano Genomics, Inc. Appoints Donna Polizio as Global Head of Market Access
CI
Bionano Genomics, Inc. Appoints Dr. Aleks Rajkovic to Its Board of Directors
CI
Bionano Genomics, Inc. Appoints Aleksandar Rajkovic as Class III Director
CI
Bionano Genomics, Inc. Appoints Vince Wong to Board of Directors
CI
Bionano Genomics, Inc. Appoints Richard Shippy as its Chief Business Officer
CI
Bionano Genomics, Inc. Appoints Jason Priar as its Chief Commercial Officer
CI
Bionano Genomics, Inc. Announces Executive Changes, Effective September 1, 2020
CI
Bionano Genomics Appoints Christopher Stewart as Its Chief Financial Officer, Effective September 1, 2020
CI
Bionano Genomics, Inc. Appoints Alka Chaubey as Chief Medical Officer, Effective August 31, 2020
CI
Bionano Genomics, Inc. Announces Resignation of Warren Robinson as Chief Commercial Officer, Effective June 19, 2020
CI
Bionano Genomics, Inc. Announces Board Appointments
CI
Bionano Genomics, Inc. Announces Board Changes
CI
Bionano Genomics, Inc. Announces Resignation of Quan Zhou from the Board of Directors, Effective December 12, 2019
CI
Bionano Genomics, Inc. Announces the Resignation of Mike Ward as Chief Financial Officer, Effective December 6, 2019
CI
Bionano Genomics, Inc Announces Resignation of Darren Cai from the Board of Directors
CI
Bionano Genomics, Inc. Appoints Kristiina Vuori as Class II Director
CI
BioNano Genomics, Inc. Announces Executive Changes
CI
BioNano Genomics, Inc. Appoints Terry Salyer as Chief Commercial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. News Bionano Genomics, Inc.
  5. Insiders